HCA Healthcare (HCA, Health Care Facilities) Stock Valuation & Fair Value Mixed on our tests
HCA Healthcare (HCA, Health Care Facilities) trades at a blended P/E of 14.6, about 11% above its historical normal valuation, with a forward growth estimate of 8.8% and a PEG of 1.67. Analysts' one-year estimates have been hit 45% of the time. Priced at its historical normal P/E of 13.2 on the same blended earnings, the 2026-10-02 close of $426.69 corresponds to about $385 a share. This is a valuation reference, not a price target.
- Price $445.01 at the 2026-10-08 close, 3.3% above the 20-day average ($430.65) and 6.2% above the 50-day ($419.11).
- RSI (14) at 62.6.
- 52-week range $359.93 to $542.23: the price is 17.9% below the high and 23.6% above the low.
The Street vs SeerForecast
Wall Street's mean price target for HCA is $454.23 across 22 analysts, 2.1% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: mixed on our tests. When the two disagree, start your digging there.
Valuation flags
- No notable valuation flags.
Verdict history
tickerseer's rating has been mixed on our tests since 2026-06-03.
Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.
Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.
Show all 37 weeks
Frequently asked questions
Is HCA Healthcare stock overvalued?
At a blended P/E of 14.6 versus its historical normal P/E of 13.2, HCA Healthcare trades about 11% above its typical valuation, with a PEG of 1.67 on 8.8% forward growth. tickerseer currently rates it mixed on our tests.
What is HCA Healthcare's fair value and PEG?
HCA Healthcare trades at a blended P/E of 14.6 against a historical normal P/E of 13.2, a PEG of 1.67, and a forward growth estimate of 8.8%. Priced at its historical normal P/E of 13.2 on the same blended earnings, the 2026-10-02 close of $426.69 corresponds to about $385 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of HCA Healthcare changed?
tickerseer's rating has been mixed on our tests since 2026-06-03.
What is the analyst price target for HCA Healthcare?
The mean Wall Street price target for HCA Healthcare is $454.23 across 22 analysts, 2.1% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Health Care Facilities. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.